{{Rsnum
|rsid=3733336
|Gene=FGF5
|Chromosome=4
|position=80286809
|Orientation=plus
|GMAF=0.309
|Gene_s=FGF5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 52.2 | 8.8
| HCB | 54.5 | 39.6 | 6.0
| JPT | 62.8 | 35.4 | 1.8
| YRI | 47.3 | 39.0 | 13.7
| ASW | 54.4 | 33.3 | 12.3
| CHB | 54.5 | 39.6 | 6.0
| CHD | 56.0 | 41.3 | 2.8
| GIH | 68.3 | 26.7 | 5.0
| LWK | 51.8 | 38.2 | 10.0
| MEX | 34.5 | 56.9 | 8.6
| MKK | 59.0 | 36.5 | 4.5
| TSI | 44.1 | 45.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=24146310
|Title=Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}